Effect of paclitaxel on carcino-embryonic antigen carcino-embryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 72-4 levels in patients with advanced gastric cancer
10.3969/j.issn.1005-1678.2017.06.057
- VernacularTitle:紫杉醇对胃癌晚期患者癌胚抗原、糖蛋白抗原19-9、糖蛋白抗原72-4水平变化的影响
- Author:
Ji MA
;
Danyang YE
- Keywords:
paclitaxel;
advanced gastric cancer;
CEA;
CA19-9;
CA72-4
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(6):152-154
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analysis the effect of paclitaxel on CEA, CA19-9 and CA72-4 levels in patients with advanced gastric cancer.Methods46 patients who were diagnosed with advanced gastric cancer in Pinghu hospital of traditional Chinese medicine were collected.All patients were randomly divided into experimental group and control group,23 cases in each group.The control group was treated with cis-platinum complexes and capecitabine, and the experimental group was treated with paclitaxel and capecitabine, after the treatment, the serum levels of CEA, CA19-9, CA72-4, vascular endothelial growth factor, endostatin and clinical curative effect were detected in all patients.ResultsAfter treatment, compared with control group,①the serum level of CEA was lower in the experimental group (P<0.05);②the serum level of CA19-9 and CA72-4 were lower in the experimental group (P<0.05);③the serum level of VEGF was lower in the experimental group (P<0.05);④the serum level of Endostatin was higher in the experimental group (P<0.05);⑤The clinical efficiency of the experimental group was higher(P<0.05).ConclusionsThe paclitaxel can significantly reduce the serumCEA, CA19-9, CA72-4 and VEGF levels, elevated serum Endostatin level in patients with advanced gastric cancer, improve the treatment effect, and have a guiding significance for clinica.
